The stock will cease trading and shareholders have received cash proceeds. Monitor Servier's pipeline integration for potential future value in related biotech holdings.
Price Chart
Executive Summary
Day One Biopharmaceuticals (DAWN) was acquired by Servier Pharmaceuticals in an all-cash transaction valued at $2.5 billion, resulting in delisting from Nasdaq and termination of all existing equity plans. The merger closed after Servier secured 85.34% of shares in a tender offer.
Key Facts
- Servier Pharmaceuticals completed acquisition of Day One Biopharmaceuticals for $2.5 billion in equity value
- All outstanding shares converted to $21.50 in cash per share
- Company delisted from Nasdaq following merger completion
- Board and officers replaced with Servier appointees
- All equity incentive plans terminated
Financial Impact
Total equity value of $2.5 billion paid in cash to shareholders
Risk Factors
- Loss of public market liquidity for former DAWN shareholders
- Integration risk of Day One's pipeline into Servier's portfolio
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-171997 |
| Document: d27888dex32.htm | 0001193125-26-171997 |
| Document: d27888dex31.htm | 0001193125-26-171997 |
| Document: 0001193125-26-171997-index-headers.html | 0001193125-26-171997 |
| Document: 0001193125-26-171997-index.html | 0001193125-26-171997 |
| Document: 0001193125-26-171997.txt | 0001193125-26-171997 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 4, 2026 21w ago | 15-12G | — | awaiting T+1 | — | — |
Apr 23, 2026 23w ago | 25-NSE | $21.53 $21.53 | · 0.00% | ▼ −0.78% | — |
Apr 23, 2026 23w ago | 8-K | $21.53 $21.53 | · 0.00% | ▼ −0.78% | — |
Apr 17, 2026 23w ago | 10-K/A | $21.48 $21.49 | ▲ +0.05% | ▲ +0.70% | — |
Mar 6, 2026 30w ago | Press Release | $21.20 $21.33 | ▲ +0.61% | ▼ −0.23% | — |
Feb 24, 2026 31w ago | 8-K | $10.92 $10.65 | ▼ −2.43% | ▼ −1.88% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access